Arena Pharmaceuticals Downgraded

Canaccord Adams downgraded Arena Pharmaceuticals Inc. (Nasdaq: ARNA) sending the stock price plummeting $1.10 to close at $3.99.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.